Back to Journals » OncoTargets and Therapy » Volume 9

Review

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

       
Total article views   HTML views PDF downloads Totals
16,796 Dovepress* 8,088+ 1,373 9,461
PubMed Central* 8,708 1,021 9,729
Totals 16,796 2,394 19,190
*Since 9 February 2016
+Since July 2016

View citations on PubMed Central and Google Scholar